Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.
TBPH
THERAVANCE BIOPHARMA INCData as of 2026 Q1 (03-31) · 13F snapshot
Summary
THERAVANCE BIOPHARMA INC (TBPH) is held by 7 tracked hedge-fund managers, a combined reported value of ~$52.21M; the largest are Seth Klarman, Michael Burry, Izzy Englander. This quarter: 1 new, 1 added, 1 trimmed, 1 closed. 1 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Gurus holding7
Congress trades1
Price$16.64vs quarter-end+2.53%
Sectors0
This quarter's moves
Top holderSeth KlarmanNew1
Added1
Trimmed / sold2
Seth KlarmanTrim
Value $35.62M1.0% of portfolio4,200,0212024 Q2
Value $7.37M16.2% of portfolio325,0002016 Q2
Value $1.59M— of portfolio215,5002021 Q3
Value $323.0K— of portfolio19,9002026 Q1
Value $198.0K— of portfolio12,2002026 Q1
Value $196.5K— of portfolio10,5002025 Q4
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Seth Klarman | $35.62M | 1.0% | Trim |
| Michael Burry | $7.37M | 16.2% | Add |
| Izzy EnglanderCALL | $1.59M | — | — |
| Ken GriffinCALL | $323.0K | — | — |
| Ken GriffinPUT | $198.0K | — | — |
| Steven CohenCALL | $196.5K | — | — |